Filter
2291
Filtered Results: 2291
Text search:
clinical
trials
Featured
Recommendations
240
New Publications
396
Language
Document type
No document type
1162
Guidelines
435
Studies & Reports
382
Manuals
103
Fact sheets
84
Strategic & Response Plan
56
Training Material
28
Situation Updates
14
Resource Platforms
12
Infographics
11
Brochures
2
Videos
2
Countries / Regions
India
112
Global
95
South Africa
53
Kenya
39
Western and Central Europe
39
Africa
38
Uganda
25
East and Southern Africa
25
Latin America and the Carribbean
25
Ethiopia
24
West and Central Africa
24
Sierra Leone
22
Russia
22
Nigeria
20
Zambia
20
Brazil
20
Liberia
18
Nepal
18
Malawi
18
Tanzania
17
Ukraine
17
Eastern Europe
17
Rwanda
16
Philippines
15
Zimbabwe
14
Germany
14
Indonesia
14
Ghana
13
Middle East and North Africa
13
Bangladesh
11
Mozambique
11
Namibia
11
South–East Asia Region
11
Congo, Democratic Republic of
10
Asia
10
Guinea
9
South Sudan
8
Peru
8
USA
7
Cameroon
7
Eastern Europe and Central Asia
7
Burkina Faso
6
Eswatini/ Swaziland
6
Botswana
6
Angola
6
Lesotho
6
Cambodia
5
Colombia
5
Chile
5
Albania
5
Thailand
4
Sudan
4
North America
4
United Kingdom
4
Senegal
3
Guinea-Bissau
3
Haiti
3
Syria
3
China
3
Argentina
3
Paraguay
3
Vietnam
3
Spain
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Pakistan
2
Iraq
2
Lebanon
2
Burundi
2
Myanmar / Burma
2
Sri Lanka
2
Laos
2
Tajikistan
2
Estonia
2
Georgia
2
France
2
Portugal
2
Morocco
1
Saudi Arabia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Chad
1
Ireland
1
Singapore
1
Benin
1
Ecuador
1
Greece
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Other region
1
Southern Africa
1
Canada
1
Bulgaria
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Jamaica
1
Denmark
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
562
Clinical Guidelines
353
Public Health
154
Women & Child Health
136
Key Resources
37
Pharmacy & Technologies
34
Capacity Building
21
Toolboxes
COVID-19
305
Mental Health
291
HIV
236
TB
187
NCDs
96
NTDs
94
AMR
72
Ebola
62
Pharmacy
59
Caregiver
57
Rapid Response
56
Disability
27
Planetary Health
24
Global Health Education
22
Refugee
18
Polio
13
Conflict
13
Cholera
11
Zika
11
Health Financing Toolbox
8
Natural Hazards
4
Social Ethics
4
Specific Hazards
2
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Technology landscape
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
Data for Action March 2022, Issue 5
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
Acupuncture has been practised for more than 2500 years in the Western Pacific Region and has become a global therapeutic method in recent decades. However, it was reportedthat acupuncturists differed by up to 25% in the acupuncture points they used, raising doubts and uncertainty regarding the effi...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
January 2020 to December 2021
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
